Eligens
Riga
About Eligens
Eligens is a global digital health company targeting those with enough income to manage their health but lack state programs for serious elderly diseases. Operating in 70+ countries, the core offering is a digital health platform, starting with a DNA ancestry test. This test not only reveals one's roots but also identifies genetic health risks. Using AI, the same DNA data is assessed for health threats, leading to regular income from blood test referrals and telemedicine consultations. Essentially, Eligens addresses and fulfills preventative health needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $5.0M
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: eligens.io
Industries & Categories
Biotechnology, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/eligens-41803 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.